Considering that tumor microenvironments are often enriched in secreted TGF-β [19], hence it is possible that TGF-β signaling pathway could provide a favorable environment for the dysregulation of the Wnt3/β-catenin pathway in the HER2 cells. The gene discussed is TGFB1; the disease is neoplasm.